Solid Organ Transplant Complications clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Tabelecleucel in Participants With Epstein-barr Virus (EBV)-Associated Diseases
open to all eligible people
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.
at UC Davis UCLA
Last updated: